price
OV
NASDAQ · OVID
Ovid Therapeutics Inc.
Healthcare · Biotechnology
$2.16
Up+$0.08 (+3.68%)
Updated Oct 27, 2026, 6:32 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 117.35M
- P/E ratio
- -0.06
- Dividend yield
- 0.00%
- 52-week range
- $1.18 – $3.11
- Volume
- 844.07K
- Avg. volume
- 2.89M
Price performance · OVID
OVID price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 26, 2026
OVID closed at $2.16 after 21 trading sessions, down 12.40% for the selected period.
- Last close
- $2.16
- Period change
- -12.40%
- Period low
- $2.15
- Period high
- $2.54
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | $2.19 | $2.22 | $2.1213 | $2.155 | 844.07K |
| Oct 23, 2026 | $2.31 | $2.32 | $2.12 | $2.16 | 2.02M |
| Oct 22, 2026 | $2.45 | $2.50 | $2.34 | $2.37 | 1.18M |
| Oct 21, 2026 | $2.37 | $2.65 | $2.345 | $2.47 | 5.01M |
| Oct 20, 2026 | $2.19 | $2.46 | $2.175 | $2.36 | 3.67M |
| Oct 19, 2026 | $2.18 | $2.225 | $2.14 | $2.17 | 1.64M |
| Oct 16, 2026 | $2.26 | $2.30 | $2.11 | $2.15 | 1.33M |
| Oct 15, 2026 | $2.21 | $2.31 | $2.19 | $2.26 | 1.33M |
| Oct 14, 2026 | $2.18 | $2.255 | $2.09 | $2.19 | 1.64M |
| Oct 13, 2026 | $2.41 | $2.415 | $2.18 | $2.19 | 1.64M |
| Oct 12, 2026 | $2.45 | $2.4933 | $2.394 | $2.41 | 876.04K |
| Oct 9, 2026 | $2.37 | $2.475 | $2.33 | $2.46 | 1.41M |
| Oct 8, 2026 | $2.32 | $2.36 | $2.29 | $2.34 | 1.65M |
| Oct 7, 2026 | $2.36 | $2.46 | $2.34 | $2.36 | 1M |
| Oct 6, 2026 | $2.42 | $2.44 | $2.27 | $2.37 | 1.74M |
| Oct 5, 2026 | $2.38 | $2.47 | $2.29 | $2.34 | 1.2M |
| Oct 2, 2026 | $2.47 | $2.48 | $2.33 | $2.38 | 2.17M |
| Oct 1, 2026 | $2.49 | $2.53 | $2.42 | $2.43 | 1.35M |
| Sep 30, 2026 | $2.54 | $2.605 | $2.48 | $2.49 | 1.44M |
| Sep 29, 2026 | $2.47 | $2.54 | $2.42 | $2.54 | 1.16M |
| Sep 28, 2026 | $2.40 | $2.49 | $2.35 | $2.46 | 1.19M |
Latest OVID news
The latest Smart Investors Daily articles mentioning OVID.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

